Quetiapine-associated hypothyroidism in young female patients: A report of three cases

Pharmacopsychiatry

Volumn 43, Issue 6, 2010, Pages 237-239

  Poutanen, O ^a,b   Iso Koivisto, E ^a   Tyolajarvi M ^a   Leinonen, E ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CHLORPROTHIXENE; CITALOPRAM; DULOXETINE; LEVOMEPROMAZINE; LEVOTHYROXINE; LIOTHYRONINE; LITHIUM; LORAZEPAM; MIRTAZAPINE; QUETIAPINE; THYROTROPIN; THYROXINE; ZIPRASIDONE;

ADOLESCENT; ADULT; AGGRESSIVENESS; ANTIBODY TITER; ANXIETY DISORDER; ARTICLE; ASPERGER SYNDROME; BEDTIME DOSAGE; CASE REPORT; DEPRESSION; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HALLUCINATION; HUMAN; HYPOTHYROIDISM; MENTAL DISEASE; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; SUICIDAL BEHAVIOR; THYROID FUNCTION;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; THYROTROPIN; THYROXINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77956428547     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0030-1261880     Document Type: Article

References (14)

1. Seroquel (Quetiapine Fumarate) Product Monograph. Rev 05/09. Ontario, Canada Astra Zeneca 2009
2. Beer F, Heinrich H, Springer S, etal. Quetiapine in the treatment of psychotic adolescents: a case series of 23 patients with severe early onset psychosis. World J Biol Psychiatry 2007 8 38-41
3. Castro-Fornieles J, Parellada M, Soutullo CA, etal. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach. J Child Adolesc Psychopharmacol 2008 18 327-336
4. Chueire VB, Romaldini JH, Ward LS. Subclinical hypothyroidism increases the risk for depression in the elderly. Arch Gerontol Geriatr 2007 44 21-28
5. Gerlach M, Hunnerkopf R, Rothenhofer S, etal. Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders. Pharmacopsychiatry 2007 40 72-76
6. Greenspan A, Gharabawi G, Kwentus J. Thyroid dysfunction during treatment with atypical antipsychotics. J Clin Psychiatry 2005 66 1334-1335
7. Guimaraes JM, de Souza Lopes C, Baima J, etal. Depression symptoms and hypothyroidism in a population-based study of middle-aged Brazilian women. J Affect Disord 2009 117 120-123
8. Kelly DL, Conley RR. Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine. J Clin Psychiatry 2005 66 80-84
9. Kontaxakis VP, Karaiskos D, Havaki-Kontaxaki BJ, etal. Can quetiapine-induced hypothyroidism be reversible without quetiapine discontinuation? Clin Neuropharmacol 2009 32 295-296
10. McConville B, Carrero L, Sweitzer D, etal. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial. J Child Adolesc Psychopharmacol 2003 13 75-82
11. McConville BJ, Arvanitis LA, Thyrum PT, etal. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders. J Clin Psychiatry 2000 61 252-260
12. Shaw JA, Lewis JE, Pascal S, etal. A study of quetiapine: efficacy and tolerability in psychotic adolescents. J Child Adolesc Psychopharmacol 2001 11 415-424
13. Traynor K. FDA advisers wary of expanding quetiapine use: clinicians air concerns about metabolic effects, tardive dyskinesia. Am J Health Syst Pharm 2009 66 880-882
14. Walsh JP, Bremner AP, Bulsara MK, etal. Thyroid dysfunction and serum lipids: a community-based study. Clin Endocrinol (Oxf) 2005 63 670-675